LGVN Longeveron Corporation Market Valuation

The price action for Longeveron Inc. (LGVN) shown on the chart, which stands at 0.01, confirms the business's independence from market volatility due to its focus on medical innovation. The company is developing cellular therapies to combat Alzheimer's disease, where success is determined by the testing stage rather than economic conditions. The executive team is skillfully coordinating research to validate the efficacy and safety of its products.

LGVN Longeveron: Market Capitalization in the range 07/04/2022 - 11/14/2026

Analytical breakdowns for Longeveron Corporation (LGVN)

- current price and projected stock value:

Stock Price Longeveron|LGVN - Analyst Target Range

- market capitalization data:

Market Valuation Longeveron Corporation|LGVN - Total Company Value

- business book valuation details:

Net Assets per Single Share Longeveron|LGVN - Accounting Capitalization|Market Value to Book Value Ratio longeveron.com|LGVN - Company Total Asset Base

- business debt structure and liquidity details:

- business earnings and investment ratios data:

LGVN - Company Net Income|Expected Profit Longeveron Inc.|LGVN - Price to Earnings Ratio|Future Price to Earnings Longeveron Corp|LGVN - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Longeveron Corporation|LGVN - Operating income before deduction of amortization|Earnings per share for the last twelve months Longeveron|LGVN - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months longeveron.com|LGVN - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Longeveron Inc.

- sales and revenue indicators:

LGVN - Company Sales Volume|Projected Sales Volume Longeveron|LGVN - Price-to-Revenue Multiple|Forward P/S Multiple Longeveron Corporation

Initial company analysis:LGVN (Longeveron)

Manufactured products of Longeveron Corporation

Market capitalization represents the aggregate result of investor expectations, reflecting the current value of all the issuer's shares. For Longeveron Inc. (LGVN), the company's market valuation serves as an indicator of confidence in its stem cell therapy for Alzheimer's. This chart allows for the identification of points of overvaluation or fundamental undervaluation of the business. Currently, quotes are supported by positive clinical data, despite a change in leadership. Analyzing this metric is critical for determining the optimal moment for risk hedging.

Competitors of Longeveron Inc. (LGVN)